Nagel, Jens <br/><br/>
Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration.  [electronic resource] 

 -  Neuropharmacology  Dec 2006 
 - 1163-71 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2006.07.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics, Non-Narcotic--administration & dosage<br/>Animals<br/>Biotransformation--drug effects<br/>Blood-Brain Barrier<br/>Brain Chemistry--drug effects<br/>Chronic Disease<br/>Dipeptides--analysis<br/>Dose-Response Relationship, Drug<br/>Drug Evaluation, Preclinical<br/>Extracellular Fluid--chemistry<br/>Glutamate Carboxypeptidase II--antagonists & inhibitors<br/>Injections, Intraperitoneal<br/>Ligation<br/>Male<br/>Microdialysis<br/>Models, Animal<br/>Neuralgia--drug therapy<br/>Neuroprotective Agents--administration & dosage<br/>Organophosphorus Compounds--administration & dosage<br/>Pain Threshold--drug effects<br/>Pyridazines--pharmacology<br/>Quinolines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Rats, Wistar<br/>Receptors, Metabotropic Glutamate--antagonists & inhibitors<br/>Sciatic Nerve--injuries